• Something wrong with this record ?

Adipokine Levels of RBP4, Resistin and Nesfatin-1 in Women Diagnosed With Gestational Diabetes

V. Kučerová, D. Karásek, O. Krystyník, L. Štefaničková, V. Němeček, D. Friedecký

. 2024 ; 73 (6) : 1037-1048. [pub] 20241231

Status minimal Language English Country Czech Republic

Document type Journal Article

Gestational diabetes mellitus (GDM) is a common complication of pregnancy in which women without previously diagnosed diabetes develop chronic hyperglycemia during pregnancy. It is associated with a number of maternal and fetal/neonatal complications. The role of the adipokines retinol binding protein-4, resistin and nesfatin-1 in the development of GDM is relatively poorly understood, but their role in glucose metabolism is suspected and their use as early markers to predict the development of GDM is being sought. The aim of study was to determine the correlation between the levels of selected adipokines (retinol binding protein-4, resistin, nesfatin-1) in women with gestational diabetes mellitus (GDM) and healthy pregnant women and to compare their levels with other clinical and biochemical parameters. Patients with GDM had significantly higher BMI (28.4±4.5 vs. 24.6±4 kg/m2), total cholesterol (6±1.3 vs. 5.3±1.4 mmol/l) and triacylglycerols (1.9±0.8 vs. 1.4±0.7 mmol/l) than women in the control group. RBP4 confirms the significant difference between the groups, it is higher in the control group of healthy pregnant women. The adipokines resistin and nesfatin-1 show no differences between the control and GDM groups, but their ratios with BMI, cholesterol and triacylglycerols, resistin shows elevated levels in the control group. In women with GDM, RBP4 was significantly positively correlated with C-peptide and negatively correlated with total, LDL, and non-HDL cholesterol. Resistin was also negatively correlated with total, LDL, HDL, and non-HDL cholesterol. Nesfatin-1 was only moderately positively correlated with glycated hemoglobin (HbA1C) and fasting glycemia. There is ambiguity in the results of previous studies on the levels of the investigated adipokines in pregnant women with GDM and the interpretation depends on many factors. Keywords: Gestational diabetes, Adipokines, Retinol-binding protein 4, Resistin, Nesfatin-1.

000      
00000naa a2200000 a 4500
001      
bmc25005491
003      
CZ-PrNML
005      
20250312151257.0
007      
ta
008      
250213s2024 xr f 000 0|eng||
009      
AR
035    __
$a (PubMed)39903893
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kučerová, V $u Department of Clinical Biochemistry, University Hospital Olomouc, Czech Republic. Veronika.Kucerova@fnol.cz
245    10
$a Adipokine Levels of RBP4, Resistin and Nesfatin-1 in Women Diagnosed With Gestational Diabetes / $c V. Kučerová, D. Karásek, O. Krystyník, L. Štefaničková, V. Němeček, D. Friedecký
520    9_
$a Gestational diabetes mellitus (GDM) is a common complication of pregnancy in which women without previously diagnosed diabetes develop chronic hyperglycemia during pregnancy. It is associated with a number of maternal and fetal/neonatal complications. The role of the adipokines retinol binding protein-4, resistin and nesfatin-1 in the development of GDM is relatively poorly understood, but their role in glucose metabolism is suspected and their use as early markers to predict the development of GDM is being sought. The aim of study was to determine the correlation between the levels of selected adipokines (retinol binding protein-4, resistin, nesfatin-1) in women with gestational diabetes mellitus (GDM) and healthy pregnant women and to compare their levels with other clinical and biochemical parameters. Patients with GDM had significantly higher BMI (28.4±4.5 vs. 24.6±4 kg/m2), total cholesterol (6±1.3 vs. 5.3±1.4 mmol/l) and triacylglycerols (1.9±0.8 vs. 1.4±0.7 mmol/l) than women in the control group. RBP4 confirms the significant difference between the groups, it is higher in the control group of healthy pregnant women. The adipokines resistin and nesfatin-1 show no differences between the control and GDM groups, but their ratios with BMI, cholesterol and triacylglycerols, resistin shows elevated levels in the control group. In women with GDM, RBP4 was significantly positively correlated with C-peptide and negatively correlated with total, LDL, and non-HDL cholesterol. Resistin was also negatively correlated with total, LDL, HDL, and non-HDL cholesterol. Nesfatin-1 was only moderately positively correlated with glycated hemoglobin (HbA1C) and fasting glycemia. There is ambiguity in the results of previous studies on the levels of the investigated adipokines in pregnant women with GDM and the interpretation depends on many factors. Keywords: Gestational diabetes, Adipokines, Retinol-binding protein 4, Resistin, Nesfatin-1.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    12
$a nukleobindiny $x krev $7 D000080866
650    _2
$a těhotenství $7 D011247
650    12
$a resistin $x krev $7 D052243
650    12
$a plazmatické proteiny vázající retinol $x metabolismus $x analýza $7 D054839
650    12
$a gestační diabetes $x krev $x diagnóza $7 D016640
650    _2
$a dospělí $7 D000328
650    12
$a biologické markery $x krev $7 D015415
650    _2
$a proteiny vázající vápník $x krev $7 D002135
650    _2
$a DNA vazebné proteiny $x krev $7 D004268
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a krevní glukóza $x metabolismus $7 D001786
650    _2
$a proteiny nervové tkáně $x krev $7 D009419
650    _2
$a adipokiny $x krev $7 D054392
655    _2
$a časopisecké články $7 D016428
700    1_
$a Karásek, D
700    1_
$a Krystyník, O
700    1_
$a Štefaničková, L
700    1_
$a Němeček, V
700    1_
$a Friedecký, D
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 73, č. 6 (2024), s. 1037-1048
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39903893 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y - $z 0
990    __
$a 20250213 $b ABA008
991    __
$a 20250312151304 $b ABA008
999    __
$a min $b bmc $g 2283547 $s 1242511
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 73 $c 6 $d 1037-1048 $e 20241231 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
LZP    __
$a Pubmed-20250213

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...